ATE309240T1 - Chinazolin-derivate als alpha-1 adrenerge antagonisten - Google Patents
Chinazolin-derivate als alpha-1 adrenerge antagonistenInfo
- Publication number
- ATE309240T1 ATE309240T1 AT01974210T AT01974210T ATE309240T1 AT E309240 T1 ATE309240 T1 AT E309240T1 AT 01974210 T AT01974210 T AT 01974210T AT 01974210 T AT01974210 T AT 01974210T AT E309240 T1 ATE309240 T1 AT E309240T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- quinazoline derivatives
- adrenergic antagonists
- adrenergic
- antagonists
- Prior art date
Links
- 239000000674 adrenergic antagonist Substances 0.000 title 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22950300P | 2000-08-31 | 2000-08-31 | |
| PCT/EP2001/009749 WO2002018348A2 (en) | 2000-08-31 | 2001-08-23 | Quinazoline derivatives as alpha-1 adrenergic antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE309240T1 true ATE309240T1 (de) | 2005-11-15 |
Family
ID=22861517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01974210T ATE309240T1 (de) | 2000-08-31 | 2001-08-23 | Chinazolin-derivate als alpha-1 adrenerge antagonisten |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6559153B2 (enExample) |
| EP (1) | EP1315714B1 (enExample) |
| JP (1) | JP3971299B2 (enExample) |
| KR (1) | KR100602929B1 (enExample) |
| CN (1) | CN1308324C (enExample) |
| AR (1) | AR032475A1 (enExample) |
| AT (1) | ATE309240T1 (enExample) |
| AU (2) | AU2001293788B2 (enExample) |
| BR (1) | BR0113585A (enExample) |
| CA (1) | CA2420177C (enExample) |
| DE (1) | DE60114852T2 (enExample) |
| ES (1) | ES2251512T3 (enExample) |
| GT (1) | GT200100181A (enExample) |
| MX (1) | MXPA03001777A (enExample) |
| PA (1) | PA8527901A1 (enExample) |
| PE (1) | PE20020407A1 (enExample) |
| UY (1) | UY26919A1 (enExample) |
| WO (1) | WO2002018348A2 (enExample) |
| ZA (1) | ZA200301082B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322169B2 (en) | 2001-08-10 | 2008-10-30 | Monash University | Derivatives of morphine-like opioid compounds |
| US20050203100A1 (en) * | 2002-04-03 | 2005-09-15 | Jukka Sallinen | Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| ITMI20030151A1 (it) * | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
| ATE440825T1 (de) * | 2003-06-06 | 2009-09-15 | Vertex Pharma | Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern |
| EP1648878B9 (en) * | 2003-07-24 | 2011-03-16 | Euro-Celtique S.A. | Piperidine compounds and pharmaceutical compositions containing them |
| WO2006021345A2 (en) * | 2004-08-27 | 2006-03-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with adrenergic alpha-1b receptor (adra1b) |
| MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
| US7413607B2 (en) * | 2005-03-31 | 2008-08-19 | 3M Innovative Properties Company | Templated semiconductor particles and methods of making |
| US7344583B2 (en) * | 2005-03-31 | 2008-03-18 | 3M Innovative Properties Company | Methods of making metal particles within cored dendrimers |
| JP4796624B2 (ja) | 2005-05-04 | 2011-10-19 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ受容体に作用する（３，４−ジヒドロ−キナゾリン−２−イル）−（２−アリールオキシ−エチル）−アミン類 |
| WO2007125321A2 (en) | 2006-04-25 | 2007-11-08 | Astex Therapeutics Limited | Purine and deazapurine derivatives as pharmaceutical compounds |
| WO2008036700A2 (en) * | 2006-09-19 | 2008-03-27 | 3M Innovative Properties Company | Templated metal oxide particles and methods of making |
| BRPI0818533B8 (pt) | 2007-10-11 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto |
| TW200944526A (en) * | 2008-04-22 | 2009-11-01 | Vitae Pharmaceuticals Inc | Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| ME03589B (me) | 2011-04-01 | 2020-07-20 | Astrazeneca Ab | Terapeutski tretman |
| MX367640B (es) | 2011-11-30 | 2019-08-29 | Astrazeneca Ab | Tratamiento combinado del cáncer. |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
| EP3595661A4 (en) * | 2017-03-12 | 2020-08-19 | Xiaodong Wang | POLYCYCLIC AMINES USED AS MODULATORS OF OPIOID RECEPTOR |
| WO2019088095A1 (ja) * | 2017-11-02 | 2019-05-09 | 国立大学法人九州大学 | 鎮痛剤及びその使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997011698A1 (en) | 1995-09-29 | 1997-04-03 | Merck & Co., Inc. | ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| GB9526546D0 (en) * | 1995-12-23 | 1996-02-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9700504D0 (en) | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
| US6355641B1 (en) | 1999-03-17 | 2002-03-12 | Syntex (U.S.A.) Llc | Oxazolone derivatives and uses thereof |
-
2001
- 2001-08-23 KR KR1020037002933A patent/KR100602929B1/ko not_active Expired - Fee Related
- 2001-08-23 EP EP01974210A patent/EP1315714B1/en not_active Expired - Lifetime
- 2001-08-23 CA CA002420177A patent/CA2420177C/en not_active Expired - Fee Related
- 2001-08-23 JP JP2002523466A patent/JP3971299B2/ja not_active Expired - Fee Related
- 2001-08-23 AT AT01974210T patent/ATE309240T1/de not_active IP Right Cessation
- 2001-08-23 CN CNB018165958A patent/CN1308324C/zh not_active Expired - Fee Related
- 2001-08-23 DE DE60114852T patent/DE60114852T2/de not_active Expired - Fee Related
- 2001-08-23 AU AU2001293788A patent/AU2001293788B2/en not_active Ceased
- 2001-08-23 WO PCT/EP2001/009749 patent/WO2002018348A2/en not_active Ceased
- 2001-08-23 BR BR0113585-6A patent/BR0113585A/pt not_active IP Right Cessation
- 2001-08-23 AU AU9378801A patent/AU9378801A/xx active Pending
- 2001-08-23 MX MXPA03001777A patent/MXPA03001777A/es active IP Right Grant
- 2001-08-23 ES ES01974210T patent/ES2251512T3/es not_active Expired - Lifetime
- 2001-08-29 US US09/942,385 patent/US6559153B2/en not_active Expired - Fee Related
- 2001-08-29 PE PE2001000870A patent/PE20020407A1/es not_active Application Discontinuation
- 2001-08-30 GT GT200100181A patent/GT200100181A/es unknown
- 2001-08-30 AR ARP010104130A patent/AR032475A1/es unknown
- 2001-08-30 PA PA20018527901A patent/PA8527901A1/es unknown
- 2001-08-30 UY UY26919A patent/UY26919A1/es not_active Application Discontinuation
-
2003
- 2003-02-07 ZA ZA200301082A patent/ZA200301082B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2420177A1 (en) | 2002-03-07 |
| KR20030022421A (ko) | 2003-03-15 |
| CN1308324C (zh) | 2007-04-04 |
| GT200100181A (es) | 2002-05-23 |
| JP2004507527A (ja) | 2004-03-11 |
| JP3971299B2 (ja) | 2007-09-05 |
| EP1315714A2 (en) | 2003-06-04 |
| US20020045614A1 (en) | 2002-04-18 |
| AR032475A1 (es) | 2003-11-12 |
| DE60114852D1 (de) | 2005-12-15 |
| UY26919A1 (es) | 2002-02-28 |
| MXPA03001777A (es) | 2003-06-04 |
| ES2251512T3 (es) | 2006-05-01 |
| ZA200301082B (en) | 2004-05-07 |
| CA2420177C (en) | 2008-07-08 |
| EP1315714B1 (en) | 2005-11-09 |
| KR100602929B1 (ko) | 2006-07-20 |
| DE60114852T2 (de) | 2006-07-27 |
| US6559153B2 (en) | 2003-05-06 |
| AU2001293788B2 (en) | 2007-10-11 |
| AU9378801A (en) | 2002-03-13 |
| WO2002018348A2 (en) | 2002-03-07 |
| PE20020407A1 (es) | 2002-05-21 |
| WO2002018348A3 (en) | 2002-07-11 |
| CN1545510A (zh) | 2004-11-10 |
| PA8527901A1 (es) | 2002-07-30 |
| BR0113585A (pt) | 2003-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60008262D1 (de) | Piperazinderivate als 5-ht1b antagonisten | |
| EE200300071A (et) | Kinasoliini derivaadid | |
| NO20032612D0 (no) | CXCR3-antagonister | |
| NO20023424L (no) | Kortikotropin-frigjörende faktorantagonister | |
| IS2556B (is) | Nýjar kínasólín afleiður. | |
| DE60218340D1 (de) | 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten | |
| DE60026169D1 (de) | Selektive neurokinin-antagonisten | |
| MXPA03005854A (es) | Derivados de quinazolona como antagonistas del receptor adrenergico alfa 1a/b. | |
| NO20032382L (no) | LFA-1-antagonistforbindelser | |
| DE60139571D1 (de) | Muscarin-antagonisten | |
| DE60222647D1 (de) | Urea derivate als integrin alpha 4 antagonisten | |
| DE60114852D1 (de) | Chinazolin-derivate als alpha-1 adrenerge antagonisten | |
| DE60106607D1 (de) | Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten | |
| NO20041235L (no) | Kinolinderivater som neuropeptid Y antagonister | |
| DK1199356T3 (da) | Höjproduktive alfa-amylaser | |
| DE60118569D1 (de) | 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten | |
| NO20035573D0 (no) | Kinazolinderivater | |
| NO20021502D0 (no) | Kinazolinoner | |
| ATE286018T1 (de) | Biphenylderivate als neurokinin-1 antagonisten | |
| DE60009931D1 (de) | Muscarin-antagonisten | |
| NO20015237L (no) | Integrinreseptor-antagonister | |
| ATE280161T1 (de) | Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten | |
| DE50110971D1 (de) | Werkzeughalter | |
| PL362793A1 (pl) | Antagoniści reseptorów histaminowych | |
| DE60012953D1 (de) | 3-amino-2-phenylpiperidinderivate als substanz p antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1315714 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |